Our people

Andrew Pitts

Andrew Pitts

Our People

Andrew Pitts

Senior Associate, Patent Attorney

Chemistry

Munich

Our People

Our IP specialists work at all stages of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

View the team

News & Insights

We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.

Learn more

Law & Practice Guide

We believe in making it easy for you to find the information that you want – and you can always contact us if you can’t find what you need

Read our law and practice guides

Andrew has a strong background in organic, biological and medicinal chemistry, working mostly on European Patent Office prosecution and opposition cases relating to the chemistry and materials sectors.

Areas of Expertise

  • Chemistry: Small-molecule drugs, nanoparticle drug conjugates, paint compositions, agricultural fungicides, industrial chemical processes and consumer goods.
  • Materials: Graphene, carbon-fibre composites, magnets, batteries and organic electroluminescent devices.
  • Mechanical: Automobile parts, heat-not-burn devices and shavers.

Clients

Andrew primarily handles agency work coming in from Japan, China and the US. He also manages the global prosecution of patent families for UK academic clients, carries out direct European work for large Japanese companies and drafts patent applications for British SMEs and larger businesses.

Background

Andrew has an MSci (Hons.) degree in medical and biological chemistry from the University of Nottingham, with his penultimate undergraduate year spent working with AstraZeneca in Sweden. He also has a PhD in organic chemistry from the University of Cambridge, where his research focused on C–H functionalisation and natural product synthesis. Andrew joined Mewburn Ellis LLP in 2015, qualifying as a European Patent Attorney in 2019 and as a Chartered Patent Attorney in 2020.